DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lu G, Conley PB, Leeds JM. et al.
A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers.
Blood Adv 2020;
4 (04) 728-739
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.